Ambrx, Inc.
Records under this name other than the patents Ambrx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 52 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,542,310 | Modified Bovine G-CSF Polypeptides And Their Uses now held by Elanco US Inc. In force · High confidence | In force | High confidence | |
| US 10,138,283 | Modified Bovine G-CSF Polypeptides And Their Uses now held by Elanco US Inc. In force · High confidence | In force | High confidence | |
| US 10,550,190 | Phosphate Based Linkers for Intracellular Delivery of Drug Conjugates now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 11,773,150 | Antibody Peptide Conjugates That Have Agonist Activity at Both the Glucagon and Glucagon-Like Peptide 1 Receptors now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 10,800,826 | Antibody Peptide Conjugates That Have Agonist Activity at Both the Glucagon and Glucagon-Like Peptide 1 Receptors now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 11,510,993 | Antibody Drug Conjugate for Anti-Inflammatory Applications now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 7,468,458 | Accelerants for the Modification of Non-Natural Amino Acids and Non-Natural Amino Acid Polypeptides Term ended Ended no later than Nov 8, 2026 · Medium confidence | Term ended | Ended no later than Nov 8, 2026 | Medium confidence |
| US 7,888,533 | Accelerants for the Modification of Non-Natural Amino Acids and Non-Natural Amino Acid Polypeptides Term ended Term ended Nov 8, 2026 · Medium confidence | Term ended | Term ended Nov 8, 2026 | Medium confidence |
| US 11,439,710 | Nucleic Acids Encoding Modified Relaxin Polypeptides Lapsed on the fee record Ended Sep 13, 2026 · High confidence | Lapsed on the fee record | Ended Sep 13, 2026 | High confidence |
| US 7,928,163 | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides Term ended Term ended Aug 16, 2026 · Medium confidence | Term ended | Term ended Aug 16, 2026 | Medium confidence |